In the press

James Carthew comments on IEM’s exit tender in Investment Week

Biotech trusts top performance charts in February

James Carthew comments on Saba and the IEM exit tender in Michael Nelson’s article:

“Saba, through its intransigence and determination to ride roughshod over the wishes of other shareholders, has brought about the end of a unique trust..In my view, IEM shareholders should vote in favour of the tender and tender all their shares. The likely alternative is Saba seizing control, appointing itself manager (probably on a higher fee if the charges on its ETF are anything to go by), and changing the mandate,”..

Read the article here